Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0U5RT
|
||||
Former ID |
DAP000678
|
||||
Drug Name |
Primidone
|
||||
Synonyms |
Cyral; Desoxyphenobarbital; Desoxyphenobarbitone; Hexadiona; Lepimidin; Lepsiral; Liskantin; Majsolin; Midone; Milepsin; Misodine; Misolyne; Mizodin; Mizolin; Myidone; Mylepsin; Mylepsinum; Mysedon; Mysoline; Neurosyn; Prilepsin; Primacione; Primaclone; Primacone; Primakton; Primidon; Primidona; Primidonum; Primoline; Prysoline; Resimatil; Sertan; Apotex Brand of Primidone; Astra Brand of Primidone; AstraZeneca Brand of Primidone; Desitin Brand of Primidone; Draxis Brand of Primidone; Holsten Brand of Primidone; Pms Primidone; Primidon Holsten; Primidone Methanol Solution; Xcel Brand of Primidone; Zeneca Brand of Primidone; P 7295; Roe 101; Apo-Primidone; Hexamidine (the antispasmodic); Hexamidine(the antispasmodic); Liskantin (TN); Medi-Pets; Mylepsinum (TN); Mysoline (TN); Primidona [INN-Spanish]; Primidone (primaclone); Primidonum [INN-Latin]; Prysoline (TN); Pyrimidone Medi-pets; Resimatil (TN); Sanofi-Synthelabo Brand of Primidone; Sertan (TN); Apo-Primidone (TN); Pyrimidone (Medi-pets); Primidone (JP15/USP/INN); Primidone [USAN:INN:BAN:JAN]; 2-Deoxyphenobarbital; 2-Desoxyphenobarbital; 4,4'-(Hexamethylenedioxy)dibenzamidine; 5-Aethyl-5-phenyl-hexahydropyrimidin-4,6-dion; 5-Aethyl-5-phenyl-hexahydropyrimidin-4,6-dion [German]; 5-Ethyl-5-phenylhexahydropyrimidine-4,6-dione; 5-Ethyldihydro-5-phenyl-4,6(1H,5H)-pyrimidinedione; 5-Ethylhexahydro-4,6-dioxo-5-phenylpyrimidine; 5-Ethylhexahydro-5-phenylpyrimidine-4,6-dione; 5-Phenyl-5-aethylhexahydropyrimidindion-(4,6); 5-Phenyl-5-aethylhexahydropyrimidindion-(4,6) [German]; 5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione; 5-ethyl-5-phenyl-1,3-diazinane-4,6-dione; 5-ethyl-5-phenyldihydropyrimidine-4,6(1H,5H)-dione; 5-ethylhe xahydro-4,6-dioxo-5-phenylpyrimidine
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Anticonvulsants
|
||||
Company |
Rekah Pharmaceutical
|
||||
Structure |
Download2D MOL |
||||
Formula |
C12H14N2O2
|
||||
InChI |
InChI=1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16)
|
||||
InChIKey |
DQMZLTXERSFNPB-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 125-33-7
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9575, 96478, 855864, 5227599, 7847540, 7980382, 8149495, 8153020, 10506074, 11111659, 11112270, 11113350, 11335499, 11360738, 11363726, 11366288, 11368850, 11371825, 11374108, 11377012, 11461710, 11466961, 11468081, 11485061, 11486771, 11489109, 11490369, 11492300, 11494646, 15121366, 17389534, 17405579, 24277732, 26611888, 26679596, 26747018, 26747019, 26751542, 29223987, 46507775, 47291047, 47365104, 47440159, 47440160, 47440161, 47440162, 47588907, 47810657, 48184911, 48184912
|
||||
SuperDrug ATC ID |
N03AA03
|
||||
SuperDrug CAS ID |
cas=000125337
|
||||
Target and Pathway | |||||
Target(s) | Gamma-aminobutyric acid receptor subunit alpha-1 | Target Info | Antagonist | [536555] | |
References | |||||
Ref 538190 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 040586. | ||||
Ref 540777 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5338). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.